Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Dedrick

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Infection and Immunity|April 1, 1995
Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPSR L Dedrick, P J Conlon
Federation Proceedings|January 1, 1980
Species similarities in pharmacokineticsR L Dedrick, K B Bischoff
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 1998
Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodiesM F Flessner, R L Dedrick
Cancer Research|May 1, 1992
Carcinogenic potency of alkylating agents in rodents and humansR L Dedrick, P F Morrison
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouseF G King, R L Dedrick
Cancer Research|August 15, 1994
Monoclonal antibody delivery to intraperitoneal tumors in rats: effects of route of administration and intraperitoneal solution osmolalityM F Flessner, R L Dedrick
Molecular and Cellular Biology|February 1, 1990
Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factorsR L Dedrick, P P Jones
Journal of the National Cancer Institute|April 2, 1997
Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposureR L Dedrick, M F Flessner
Cancer Treatment Reports|July 1, 1977
Antifolates: in vivo kinetic considerationsD S Zaharko, R L Dedrick
Biochemical Pharmacology|May 15, 1973
Blood flow limitations in interpreting Michaelis constants for ethanol oxidation in vivoR L Dedrick, D D Forrester
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Infection and Immunity|April 1, 1995
Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPSR L Dedrick, P J Conlon
Federation Proceedings|January 1, 1980
Species similarities in pharmacokineticsR L Dedrick, K B Bischoff
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 1998
Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodiesM F Flessner, R L Dedrick
Cancer Research|May 1, 1992
Carcinogenic potency of alkylating agents in rodents and humansR L Dedrick, P F Morrison
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouseF G King, R L Dedrick
Cancer Research|August 15, 1994
Monoclonal antibody delivery to intraperitoneal tumors in rats: effects of route of administration and intraperitoneal solution osmolalityM F Flessner, R L Dedrick
Molecular and Cellular Biology|February 1, 1990
Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factorsR L Dedrick, P P Jones
Journal of the National Cancer Institute|April 2, 1997
Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposureR L Dedrick, M F Flessner
Cancer Treatment Reports|July 1, 1977
Antifolates: in vivo kinetic considerationsD S Zaharko, R L Dedrick
Biochemical Pharmacology|May 15, 1973
Blood flow limitations in interpreting Michaelis constants for ethanol oxidation in vivoR L Dedrick, D D Forrester
Pageof 14